Publications by authors named "Alessandro Cellini"

Claim this Profile
A
An Uncommon Localization of Hairy Cell Leukemia: Central Nervous System Involvement and Response to Ibrutinib-A Case Report and a Review of the Literature.
Giovanni Leone, Mattia D'Antiga, Michela Pelloso, Andrea Serafin, Nicolò Danesin, Alessandro Cellini

Am J Hematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study.
Andrea Visentin, Enrico Gaffo, Moritz Fürstenau, Kerry A Rogers, Baliakas Panagiotis, Alessandro Cellini

Leukemia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extent of bone marrow infiltration predicts disease progression in asymptomatic Waldenström macroglobulinemia.
Nicolò Danesin, Giovanni Leone, Mattia D'Antiga, Greta Scapinello, Marco Carraro, Alessandro Cellini

Discov Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax and ibrutinib: Two partners for the front-line treatment of chronic lymphocytic leukemia.
Andrea Visentin, Alessandro Cellini, Francesco Angotzi, Sara Pepe, Francesca Romana Mauro

Crit Rev Oncol Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum soluble interleukin-2 receptor levels in hairy cell leukaemia as a marker of tumour burden with prognostic value and as a tool for disease monitoring.
Francesco Angotzi, Alessandro Cellini, Nicolò Danesin, Simone Zoletto, Andrea Serafin

Br J Haematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central Nervous System Involvement in CLL: An International Retrospective Study by ERIC, the European Research Initiative on CLL.
Thomas Chatzikonstantinou, Mariia Mikhaleva, Christian Brieghel, Christina Papangelou, Evangelia Minga, Alessandro Cellini

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, prevention and management of severe infections in patients undergoing therapy for chronic lymphocytic leukemia.
Arianna Bevilacqua, Alessandro Cellini, Francesco Angotzi, Andrea Serafin, Federica Mazzetto

Expert Rev Hematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Richter transformation in diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia receiving ibrutinib: risk factors and outcomes.
Sara Pepe, Candida Vitale, Diana Giannarelli, Andrea Visentin, Alessandro Sanna, Alessandro Cellini

Leukemia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohort.
Andrea Serafin, Alessandro Cellini, Enrica Antonia Martino, Federica Mazzetto, Francesco Angotzi

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting thrombotic risk in patients with classical Hodgkin lymphoma: Thro-HL multicenter study.
Giovanni Manfredi Assanto, Eleonora Alma, Alessandro Cellini, Giovanni Marsili, Gianluca Maiorana

Hemasphere· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study.
Eleonora Roncaglia, Enrico Gaffo, Giulia Calabretto, Moritz Fürstenau, Kerry A Rogers, Alessandro Cellini

J Hematol Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVD.
Chiara Rusconi, Angelica Barone, Andrea Visentin, Benedetta Bianchi, Vittorio Ruggero Zilioli, Alessandro Cellini

Leuk Lymphoma· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management strategies for patients with chronic lymphocytic leukaemia harbouring complex karyotype.
Andrea Serafin, Valeria Ruocco, Alessandro Cellini, Francesco Angotzi, Laura Bonaldi

Br J Haematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arsenic trioxide-induced peripheral neuropathy: prospective clinical and neurophysiological evaluation in a cohort of patients with acute promyelocytic leukemia.
Alessandro Cellini, Alessandro Salvalaggio, Roser Velasco, Montserrat Arnan, Mario Cacciavillani

Leuk Lymphoma· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD.
Alessandro Cellini, Chiara Adele Cavarretta, Francesco Angotzi, Valeria Ruocco, Andrea Serafin

Front Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience.
Nicolò Danesin, Laura Bonaldi, Annalisa Martines, Silvia Nalio, Roberta Bertorelle, Alessandro Cellini

Ann Hematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax-based regimens.
Andrea Serafin, Alessandro Cellini, Chiara Adele Cavarretta, Valeria Ruocco, Francesco Angotzi

Br J Haematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy.
Edoardo Ruggeri, Federica Frezzato, Nayla Mouawad, Marco Pizzi, Federico Scarmozzino, Alessandro Cellini

Front Immunol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bleomycin-induced flagellate dermatitis in a patient with Hodgkin lymphoma.
Nicolò Danesin, Alessandro Cellini, Francesco Piazza, Livio Trentin, Andrea Visentin

Med Clin (Barc)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course.
Francesco Angotzi, Alessandro Cellini, Valeria Ruocco, Chiara Adele Cavarretta, Ivan Zatta

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The added value of karyotype in predicting the need for therapy in chronic lymphocytic leukemia with 13q deletion.
Annalisa Martines, Angela Grassi, Andrea Visentin, Monica Facco, Silvia Nalio, Alessandro Cellini

Hematol Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study.
Andrea Visentin, Francesca Romana Mauro, Lydia Scarfò, Massimo Gentile, Lucia Farina, Alessandro Cellini

Am J Hematol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational Profile in 75 Patients With Anti-Myelin-Associated Glycoprotein Neuropathy: Clinical and Hematologic Therapy Response and Hints on New Therapeutic Targets.
Francesca Castellani, Andrea Visentin, Erika Schirinzi, Alessandro Salvalaggio, Mario Cacciavillani, Alessandro Cellini

Neurol Neuroimmunol Neuroinflamm· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies.
Francesco Angotzi, Marco Petrella, Tamara Berno, Gianni Binotto, Giorgia Bonetto, Alessandro Cellini

Front Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells.
Alessandro Cellini, Federico Scarmozzino, Francesco Angotzi, Edoardo Ruggeri, Angelo Paolo Dei Tos

Front Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis